Sunday, 25 Oct 2026

Empowering Chinese Pharma’s Global Expansion

Contact US
Insight,  China's Pharmaceutical Industry
  • Home
  • About US
  • Policy Hub
  • Categories
    • Drug
    • Company
    • Deals
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Legal / IP
    • Digital
  • Privacy Policy
  • Contact US
My News
  • Cancer
  • Clinical trial approval / initiation
  • Product approvals
  • Clinical trial results
  • Finance
  • ADC / XDC
  • Finanical Reports
  • Biotech
  • Market approval filings
  • PD-1/L1
Insight,  China's Pharmaceutical IndustryInsight,  China's Pharmaceutical Industry
  • Read History
Search
  • Pages
    • Home
    • Blog Index
    • POLICY HUB
    • Contact Us
  • Personalized
    • Read History
  • Categories
    • Company
    • Drug
    • Policy / Regulatory
    • Medical Device
    • R&D
    • Digital
    • Legal / IP
    • Deals
Have an existing account? Sign In
Follow US
Salipro Biotech and Boehringer Ingelheim Collaborate on Drug Development for Membrane Proteins
CompanyDeals

Salipro Biotech and Boehringer Ingelheim Collaborate on Drug Development for Membrane Proteins

March 14, 2025
CSPC Pharmaceutical Group Receives FDA Approval for SYH2051 Clinical Trial
CompanyDrug

CSPC Pharmaceutical Group Receives FDA Approval for SYH2051 Clinical Trial

March 14, 2025
Gaush Meditech's ANTERION Ophthalmic Detector Receives NMPA Market Approval
CompanyMedical Device

Gaush Meditech’s ANTERION Ophthalmic Detector Receives NMPA Market Approval

March 14, 2025
Bio-Thera Solutions' BAT2506 Biosimilar Accepted for Review by China's NMPA
CompanyDrug

Bio-Thera Solutions’ BAT2506 Biosimilar Accepted for Review by China’s NMPA

March 14, 2025
Otsuka and Lundbeck Win EU Approval for Rxulti in Adolescent Schizophrenia
CompanyDrug

Otsuka and Lundbeck Win EU Approval for Rxulti in Adolescent Schizophrenia

March 14, 2025
Shanghai Fosun Pharmaceutical Gains NMPA Approval for XH-S003 in PNH Treatment
CompanyDrug

Shanghai Fosun Pharmaceutical Gains NMPA Approval for XH-S003 in PNH Treatment

March 14, 2025
Trinomab Biotech Launches Xintituo for Tetanus Treatment in Zhuhai
CompanyDrug

Trinomab Biotech Launches Xintituo for Tetanus Treatment in Zhuhai

March 14, 2025
Tasly Pharma's NR-20201 Receives NMPA Approval for Acute Ischemic Stroke Trial
CompanyDrug

Tasly Pharma’s NR-20201 Receives NMPA Approval for Acute Ischemic Stroke Trial

March 14, 2025
Jiangsu Aidea's AD108 Receives NMPA Approval for Acute Ischemic Stroke
CompanyDrug

Jiangsu Aidea’s AD108 Receives NMPA Approval for Acute Ischemic Stroke

March 14, 2025
Insilico Medicine Closes USD110 Million Series E Round to Advance AI-Driven Drug Pipeline
CompanyDeals

Insilico Medicine Closes USD110 Million Series E Round to Advance AI-Driven Drug Pipeline

March 14, 2025
Sanyou Medical Raises RMB214 Million for Stake in SMTP Technology
CompanyDeals

Sanyou Medical Raises RMB214 Million for Stake in SMTP Technology

March 14, 2025
Gaush Meditech Receives NMPA Approval for Femtosecond Laser Corneal Refractive Surgery System
CompanyMedical Device

Gaush Meditech Receives NMPA Approval for Femtosecond Laser Corneal Refractive Surgery System

March 14, 2025
1 2 … 17 18 19 20 21 … 31 32
Insight,  China's Pharmaceutical Industry

Information You Can Trust: Stay instantly connected with breaking stories and live updates. From politics and technology to entertainment and beyond, we provide real-time coverage you can rely on, making us your dependable source for 24/7 news.

Youtube Medium Rss

About Company

  • Contact Us
  • Advertise with US
  • Complaint
  • Our Team
  • Our Values
  • Privacy Policy
Subscribe Now for Real-time Updates on the Latest Stories!

© 2026 Fineline Information & Technology. Independent intelligence on China’s pharmaceutical industry.  All Rights Reserved.

Fineline Information & Technology
Welcome to Fineline Cube!
Username or Email Address
Password

Lost your password?

Not a member? Sign Up